Process View
The movement of a myeloid dendritic cell in response to an external stimulus.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "myeloid dendritic cell chemotaxis"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CCR5 | chemokine (C-C motif) receptor 5 | 1.000 | Human | |
| CCL5 | chemokine (C-C motif) ligand 5 | 1.000 | Human | |
| CCL4 | chemokine (C-C motif) ligand 4 | 1.000 | Human | |
| CCL22 | chemokine (C-C motif) ligand 22 | 1.000 | Human | |
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 1.000 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 1.000 | ||
| CCR2 | chemokine (C-C motif) receptor 2 | 0.999 | Human | |
| IL8 | interleukin 8 | 0.998 | ||
| IFNG | interferon, gamma | 0.997 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.996 | Human | |
| CCL3 | chemokine (C-C motif) ligand 3 | 0.994 | Human | |
| CCL2 | chemokine (C-C motif) ligand 2 | 0.993 | Human | |
| CCR4 | chemokine (C-C motif) receptor 4 | 0.993 | Human | |
| CCL19 | chemokine (C-C motif) ligand 19 | 0.992 | ||
| IL2RB | interleukin 2 receptor, beta | 0.991 | ||
| IL1B | interleukin 1, beta | 0.984 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.967 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.966 | Human | |
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.964 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.953 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.944 | ||
| IL10 | interleukin 10 | 0.932 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.928 | ||
| LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.922 | ||
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.920 | ||
| SLAMF7 | SLAM family member 7 | 0.916 | ||
| IRF4 | interferon regulatory factor 4 | 0.914 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.912 | Human | |
| CCL13 | chemokine (C-C motif) ligand 13 | 0.892 | Human | |
| TNF | tumor necrosis factor | 0.886 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.869 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.849 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.815 | ||
| CD40LG | CD40 ligand | 0.791 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.780 | ||
| IL16 | interleukin 16 (lymphocyte chemoattractant factor) | 0.758 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.724 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.715 | Human | |
| CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.667 | Human | |
| CCR1 | chemokine (C-C motif) receptor 1 | 0.616 | Human | |
| CCL20 | chemokine (C-C motif) ligand 20 | 0.584 | Human | |
| IL10RA | interleukin 10 receptor, alpha | 0.558 | ||
| CD2 | CD2 molecule | 0.548 | ||
| CD83 | CD83 molecule | 0.521 | ||
| IDE | insulin-degrading enzyme | 0.483 | ||
| IL7R | interleukin 7 receptor | 0.442 | ||
| KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.440 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.432 | ||
| CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.424 | Human | |
| UBD | ubiquitin D | 0.420 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.406 | ||
| CCR6 | chemokine (C-C motif) receptor 6 | 0.377 | Human | |
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.365 | ||
| CCR8 | chemokine (C-C motif) receptor 8 | 0.363 | Human | |
| SELE | selectin E | 0.356 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.350 | ||
| IL21R | interleukin 21 receptor | 0.338 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.307 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.305 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.294 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.267 | ||
| CLEC7A | C-type lectin domain family 7, member A | 0.244 | ||
| IL18RAP | interleukin 18 receptor accessory protein | 0.234 | ||
| DARC | Duffy blood group, chemokine receptor | 0.209 | ||
| FPR3 | formyl peptide receptor 3 | 0.196 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.193 | Human | |
| KLRB1 | killer cell lectin-like receptor subfamily B, member 1 | 0.190 | ||
| CD80 | CD80 molecule | 0.185 | ||
| LAG3 | lymphocyte-activation gene 3 | 0.178 | ||
| TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | 0.176 | ||
| CXCR2 | chemokine (C-X-C motif) receptor 2 | 0.169 | Human | |
| STAT4 | signal transducer and activator of transcription 4 | 0.168 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.165 | ||
| IL1A | interleukin 1, alpha | 0.160 | ||
| EBI3 | Epstein-Barr virus induced 3 | 0.155 | ||
| CD86 | CD86 molecule | 0.155 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.146 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.145 | ||
| CH25H | cholesterol 25-hydroxylase | 0.139 | ||
| IL1F5 | interleukin 1 family, member 5 (delta) | 0.133 | ||
| CLEC10A | C-type lectin domain family 10, member A | 0.128 | ||
| GPR171 | G protein-coupled receptor 171 | 0.127 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.127 | ||
| CCR9 | chemokine (C-C motif) receptor 9 | 0.122 | Human | |
| BCL2A1 | BCL2-related protein A1 | 0.121 | ||
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.121 | ||
| CCL17 | chemokine (C-C motif) ligand 17 | 0.116 | Human | |
| XCL1 | chemokine (C motif) ligand 1 | 0.111 | Human | |
| LAMP3 | lysosomal-associated membrane protein 3 | 0.111 | ||
| CD28 | CD28 molecule | 0.109 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.106 | ||
| IL2RA | interleukin 2 receptor, alpha | 0.105 | ||
| IDO1 | indoleamine 2,3-dioxygenase 1 | 0.104 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.102 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.100 | ||
| SIT1 | signaling threshold regulating transmembrane adaptor 1 | 0.100 | ||
| GZMK | granzyme K (granzyme 3; tryptase II) | 0.096 | ||
| IL4 | interleukin 4 | 0.094 | ||
| CD84 | CD84 molecule | 0.088 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.082 | ||
| DNASE1L3 | deoxyribonuclease I-like 3 | 0.081 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.077 | ||
| IGSF6 | immunoglobulin superfamily, member 6 | 0.076 | ||
| TM7SF4 | transmembrane 7 superfamily member 4 | 0.073 | ||
| ARRB1 | arrestin, beta 1 | 0.071 | ||
| CD69 | CD69 molecule | 0.068 | ||
| CCL21 | chemokine (C-C motif) ligand 21 | 0.067 | ||
| SELL | selectin L | 0.067 | ||
| C2 | complement component 2 | 0.065 | ||
| XCL2 | chemokine (C motif) ligand 2 | 0.063 | Human | |
| CD1B | CD1b molecule | 0.063 | ||
| OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.060 | ||
| CCL23 | chemokine (C-C motif) ligand 23 | 0.058 | Human | |
| AQP9 | aquaporin 9 | 0.057 | ||
| SELP | selectin P (granule membrane protein 140kDa, antigen CD62) | 0.056 | ||
| GPR109B | G protein-coupled receptor 109B | 0.055 | ||
| CD160 | CD160 molecule | 0.054 | ||
| HLA-DQB2 | major histocompatibility complex, class II, DQ beta 2 | 0.050 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.050 | ||
| XCR1 | chemokine (C motif) receptor 1 | 0.050 | Human | |
| PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.049 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.049 | ||
| IL18R1 | interleukin 18 receptor 1 | 0.047 | ||
| RUNX3 | runt-related transcription factor 3 | 0.047 | ||
| CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.046 | Human | |
| LTB | lymphotoxin beta (TNF superfamily, member 3) | 0.046 | ||
| CLC | Charcot-Leyden crystal protein | 0.046 | ||
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.046 | ||
| MSC | musculin | 0.045 | ||
| CXCR1 | chemokine (C-X-C motif) receptor 1 | 0.045 | Human | |
| APOC1 | apolipoprotein C-I | 0.045 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.044 | ||
| TARP | TCR gamma alternate reading frame protein | 0.043 | ||
| GPR18 | G protein-coupled receptor 18 | 0.042 | ||
| SPOCK2 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 | 0.042 | ||
| MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.042 | ||
| PDCD1LG2 | programmed cell death 1 ligand 2 | 0.042 | ||
| ITK | IL2-inducible T-cell kinase | 0.041 | ||
| IL11 | interleukin 11 | 0.041 | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.041 | Human | |
| CD48 | CD48 molecule | 0.041 | ||
| KLRK1 | killer cell lectin-like receptor subfamily K, member 1 | 0.040 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.040 | ||
| ICOS | inducible T-cell co-stimulator | 0.039 | ||
| IL6R | interleukin 6 receptor | 0.038 | ||
| CHI3L2 | chitinase 3-like 2 | 0.038 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.036 | ||
| CLEC4E | C-type lectin domain family 4, member E | 0.035 | ||
| FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | 0.035 | ||
| HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.034 | ||
| GNAO1 | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O | 0.034 | ||
| PRDM1 | PR domain containing 1, with ZNF domain | 0.034 | ||
| TBX21 | T-box 21 | 0.034 | ||
| SLAMF8 | SLAM family member 8 | 0.033 | ||
| TREM1 | triggering receptor expressed on myeloid cells 1 | 0.033 | ||
| MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.031 | ||
| C3AR1 | complement component 3a receptor 1 | 0.031 | ||
| CD1C | CD1c molecule | 0.031 | ||
| P2RY10 | purinergic receptor P2Y, G-protein coupled, 10 | 0.031 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.031 | ||
| RGS16 | regulator of G-protein signaling 16 | 0.030 | ||
| CD3G | CD3g molecule, gamma (CD3-TCR complex) | 0.030 | ||
| CCRL2 | chemokine (C-C motif) receptor-like 2 | 0.030 | Human | |
| INHBA | inhibin, beta A | 0.030 | ||
| BIN2 | bridging integrator 2 | 0.030 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.029 | ||
| IL12RB1 | interleukin 12 receptor, beta 1 | 0.029 | ||
| CCBP2 | chemokine binding protein 2 | 0.029 | Human | |
| CLEC5A | C-type lectin domain family 5, member A | 0.029 | ||
| CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.029 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.028 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.028 | ||
| LAIR2 | leukocyte-associated immunoglobulin-like receptor 2 | 0.028 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.028 | ||
| IL1F9 | interleukin 1 family, member 9 | 0.027 | ||
| CMKLR1 | chemokine-like receptor 1 | 0.027 | ||
| C5AR1 | complement component 5a receptor 1 | 0.026 | ||
| CD226 | CD226 molecule | 0.026 | ||
| RNASE2 | ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) | 0.026 | ||
| CD1A | CD1a molecule | 0.026 | ||
| MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.025 | ||
| SPP1 | secreted phosphoprotein 1 | 0.025 | ||
| ITGAM | integrin, alpha M (complement component 3 receptor 3 subunit) | 0.025 | ||
| PRAF2 | PRA1 domain family, member 2 | 0.025 | ||
| LILRB5 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 | 0.024 | ||
| SLAMF6 | SLAM family member 6 | 0.024 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.024 | ||
| C3 | complement component 3 | 0.024 | ||
| CD79A | CD79a molecule, immunoglobulin-associated alpha | 0.024 | ||
| DPT | dermatopontin | 0.023 | ||
| FMO1 | flavin containing monooxygenase 1 | 0.023 | ||
| IL32 | interleukin 32 | 0.023 | ||
| TNFRSF4 | tumor necrosis factor receptor superfamily, member 4 | 0.022 | ||
| CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.022 | ||
| SCARF1 | scavenger receptor class F, member 1 | 0.022 | ||
| IL24 | interleukin 24 | 0.022 | ||
| LY9 | lymphocyte antigen 9 | 0.021 | ||
| NPL | N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) | 0.021 | ||
| KCNJ15 | potassium inwardly-rectifying channel, subfamily J, member 15 | 0.020 | ||
| EGFL6 | EGF-like-domain, multiple 6 | 0.020 | ||
| WISP1 | WNT1 inducible signaling pathway protein 1 | 0.020 | ||
| MEOX1 | mesenchyme homeobox 1 | 0.020 | ||
| UBASH3A | ubiquitin associated and SH3 domain containing A | 0.020 | ||
| IRF8 | interferon regulatory factor 8 | 0.020 | ||
| NLRP3 | NLR family, pyrin domain containing 3 | 0.020 | ||
| PLA2G2D | phospholipase A2, group IID | 0.020 | ||
| IL13 | interleukin 13 | 0.019 | ||
| SLC2A5 | solute carrier family 2 (facilitated glucose/fructose transporter), member 5 | 0.019 | ||
| MSR1 | macrophage scavenger receptor 1 | 0.019 | ||
| CD4 | CD4 molecule | 0.018 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.018 | ||
| KMO | kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) | 0.018 | ||
| CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | 0.018 | ||
| CD209 | CD209 molecule | 0.018 | ||
| GZMH | granzyme H (cathepsin G-like 2, protein h-CCPX) | 0.018 | ||
| CIITA | class II, major histocompatibility complex, transactivator | 0.018 | ||
| SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.017 | ||
| TLR7 | toll-like receptor 7 | 0.017 | ||
| SPIB | Spi-B transcription factor (Spi-1/PU.1 related) | 0.017 | ||
| PI3 | peptidase inhibitor 3, skin-derived | 0.017 | ||
| CMA1 | chymase 1, mast cell | 0.017 | ||
| CCL1 | chemokine (C-C motif) ligand 1 | 0.017 | Human | |
| IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.017 | ||
| NKG7 | natural killer cell group 7 sequence | 0.017 | ||
| LTF | lactotransferrin | 0.017 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.017 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.017 | ||
| MMP19 | matrix metallopeptidase 19 | 0.017 | ||
| BDKRB1 | bradykinin receptor B1 | 0.017 | ||
| APLNR | apelin receptor | 0.017 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.017 | ||
| TNIP3 | TNFAIP3 interacting protein 3 | 0.017 | ||
| TNFRSF25 | tumor necrosis factor receptor superfamily, member 25 | 0.016 | ||
| PDPN | podoplanin | 0.016 | ||
| IL7 | interleukin 7 | 0.016 | ||
| P2RY6 | pyrimidinergic receptor P2Y, G-protein coupled, 6 | 0.016 | ||
| TPSB2 | tryptase beta 2 (gene/pseudogene) | 0.016 | ||
| PTPRE | protein tyrosine phosphatase, receptor type, E | 0.016 | ||
| SASH3 | SAM and SH3 domain containing 3 | 0.015 | ||
| TLR2 | toll-like receptor 2 | 0.015 | ||
| OSMR | oncostatin M receptor | 0.015 | ||
| ZBED2 | zinc finger, BED-type containing 2 | 0.015 | ||
| EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.015 | ||
| AOAH | acyloxyacyl hydrolase (neutrophil) | 0.015 | ||
| IL4I1 | interleukin 4 induced 1 | 0.015 | ||
| LRRC32 | leucine rich repeat containing 32 | 0.015 | ||
| FCN1 | ficolin (collagen/fibrinogen domain containing) 1 | 0.015 | ||
| GPR84 | G protein-coupled receptor 84 | 0.015 | ||
| ABI3BP | ABI family, member 3 (NESH) binding protein | 0.015 | ||
| IL12A | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | 0.014 | ||
| CTSG | cathepsin G | 0.014 | ||
| ADORA3 | adenosine A3 receptor | 0.014 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.014 | ||
| EDN1 | endothelin 1 | 0.014 | ||
| CX3CL1 | chemokine (C-X3-C motif) ligand 1 | 0.014 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.014 | ||
| NFE2L3 | nuclear factor (erythroid-derived 2)-like 3 | 0.014 | ||
| EVI2B | ecotropic viral integration site 2B | 0.014 | ||
| TRAF3IP3 | TRAF3 interacting protein 3 | 0.014 | ||
| CD7 | CD7 molecule | 0.014 | ||
| CHIT1 | chitinase 1 (chitotriosidase) | 0.013 | ||
| GP1BA | glycoprotein Ib (platelet), alpha polypeptide | 0.013 | ||
| IL3RA | interleukin 3 receptor, alpha (low affinity) | 0.013 | ||
| TFEC | transcription factor EC | 0.013 | ||
| GPR183 | G protein-coupled receptor 183 | 0.013 | ||
| KRT1 | keratin 1 | 0.013 | ||
| TCL1A | T-cell leukemia/lymphoma 1A | 0.013 | ||
| CD1E | CD1e molecule | 0.013 | ||
| KCNJ2 | potassium inwardly-rectifying channel, subfamily J, member 2 | 0.013 | ||
| GNAQ | guanine nucleotide binding protein (G protein), q polypeptide | 0.013 | ||
| FFAR2 | free fatty acid receptor 2 | 0.013 | ||
| C4orf7 | chromosome 4 open reading frame 7 | 0.013 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.013 | ||
| NCR3 | natural cytotoxicity triggering receptor 3 | 0.013 | ||
| CLEC4D | C-type lectin domain family 4, member D | 0.013 | ||
| PLA2G2A | phospholipase A2, group IIA (platelets, synovial fluid) | 0.013 | ||
| IL21 | interleukin 21 | 0.013 | ||
| LILRA4 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4 | 0.013 | ||
| DUSP2 | dual specificity phosphatase 2 | 0.013 | ||
| CRTAM | cytotoxic and regulatory T cell molecule | 0.012 | ||
| RGL1 | ral guanine nucleotide dissociation stimulator-like 1 | 0.012 | ||
| CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 0.012 | ||
| MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 0.012 | ||
| IL23A | interleukin 23, alpha subunit p19 | 0.012 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.012 | ||
| IL9 | interleukin 9 | 0.012 | ||
| IL17A | interleukin 17A | 0.011 | ||
| TMPRSS4 | transmembrane protease, serine 4 | 0.011 | ||
| CYP7B1 | cytochrome P450, family 7, subfamily B, polypeptide 1 | 0.011 | ||
| STEAP4 | STEAP family member 4 | 0.011 | ||
| CTSE | cathepsin E | 0.011 | ||
| ZC3H12A | zinc finger CCCH-type containing 12A | 0.011 | ||
| GZMM | granzyme M (lymphocyte met-ase 1) | 0.011 | ||
| PCDHA4 | protocadherin alpha 4 | 0.011 | ||
| RNASE3 | ribonuclease, RNase A family, 3 | 0.011 | ||
| SDS | serine dehydratase | 0.011 | ||
| LY86 | lymphocyte antigen 86 | 0.011 | ||
| VPREB3 | pre-B lymphocyte 3 | 0.011 | ||
| CSF3 | colony stimulating factor 3 (granulocyte) | 0.011 | ||
| GPR132 | G protein-coupled receptor 132 | 0.011 | ||
| NRP2 | neuropilin 2 | 0.011 | ||
| FAP | fibroblast activation protein, alpha | 0.011 | ||
| EPYC | epiphycan | 0.011 | ||
| CD79B | CD79b molecule, immunoglobulin-associated beta | 0.011 | ||
| CYTIP | cytohesin 1 interacting protein | 0.010 | ||
| CCL24 | chemokine (C-C motif) ligand 24 | 0.010 | Human | |
| PVRIG | poliovirus receptor related immunoglobulin domain containing | 0.010 | ||
| ARAF | v-raf murine sarcoma 3611 viral oncogene homolog | 0.010 | ||
| MMP13 | matrix metallopeptidase 13 (collagenase 3) | 0.010 | ||
| PLA1A | phospholipase A1 member A | 0.010 | ||
| CTSW | cathepsin W | 0.010 | ||
| CD8A | CD8a molecule | 0.010 | ||
| C7 | complement component 7 | 0.010 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.010 | ||
| SIRPB1 | signal-regulatory protein beta 1 | 0.010 | ||
| CYBB | cytochrome b-245, beta polypeptide | 0.010 | ||
| IFNB1 | interferon, beta 1, fibroblast | 0.010 | ||
| FEZ1 | fasciculation and elongation protein zeta 1 (zygin I) | 0.010 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.010 | ||
| TREM2 | triggering receptor expressed on myeloid cells 2 | 0.010 | ||
| IL18 | interleukin 18 (interferon-gamma-inducing factor) | 0.010 |